Effects of 3'-MeDAB on Rat Liver Mitochondria
Author Information
Author(s): A. O. Hawtrey, C. A. Schoeman, J. Dijkstra, Vera Schirren, L. Nourse
Primary Institution: National Chemical Research Laboratory and the National Nutrition Research Institute, South African Council for Scientific and Industrial Research
Hypothesis
A single large dose of the carcinogen 3'-MeDAB will affect mitochondrial function in rat liver.
Conclusion
The study found that 3'-MeDAB significantly inhibits the oxidation of isocitrate and citrate in rat liver mitochondria.
Supporting Evidence
- Isocitrate and citrate oxidations were inhibited by 74% and 65% respectively at 120 hours after dye feeding.
- Binding of 3'-MeDAB to mitochondrial protein peaked at 40-45 hours after administration.
- The inhibition of isocitrate and citrate oxidation was reversed by the addition of NAD plus nicotinamide.
- Mitochondrial ornithine transcarbamylase activity decreased progressively after 3'-MeDAB administration.
- No structural damage to the mitochondrial membrane was found.
Takeaway
When rats were given a chemical called 3'-MeDAB, it made their liver cells work less well for a while, especially with certain food breakdown processes.
Methodology
Rats were fed a single dose of 3'-MeDAB, and mitochondrial function was assessed by measuring oxygen uptake and enzyme activity at various time points.
Potential Biases
Potential bias in the selection of animal models and the specific conditions under which experiments were conducted.
Limitations
The study only examined short-term effects and did not explore long-term consequences of 3'-MeDAB exposure.
Participant Demographics
Male albino rats, 200-250 g body weight.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website